Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
new york
4
×
new york blog main
new york top stories
amgen
boston blog main
boston top stories
inclisiran
national top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
biotech
cholesterol
pcsk9
pcsk9 inhibitors
praluent
repatha
san francisco blog main
san francisco top stories
sanofi
the medicines co.
acute migrane
alirocumab
bain capital
bausch health
breast cancer
data
deals
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
evolocumab
fda
generic drug
glaxosmithkline
impel neuropharma
ldl
mark timney
What
drug
4
×
cholesterol
medco
medicines
fda
lowering
twice
aces
acquire
activity
agreed
announced
big
billion
biotech
bringing
brings
cash
ceo
clears
closer
companies
company
compound
days
deal
dog
filing
firm
flexible
hasn’t
inched
inclisiran
ipo
ipos
key
leading
line
market
meant
Language
unset
4
×
Current search:
" new york "
×
drug
×
unset
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs